Instructions for Rhinostop extra (Oxymetazoline) spray 15 ml
English product name
Rinostop Extra
Release Form
nasal drops 0.01%: fl. 5 ml, 10 ml or 15 ml
Description Rhinostop extra
Nasal drops in the form of transparent, colorless or yellowish solution.
1 ml
oxymetazoline hydrochloride 0.1 mg
Auxiliary substances: citric acid monohydrate - 0.6093 mg, sodium citrate dihydrate - 3.823 mg, glycerol - 24.348 mg, benzalkonium chloride solution 50% - 0.1 mg, water purified - up to 1 ml.
5 ml - bottles with drip (1) - packs of cardboard.
10 ml - bottles with drip (1) - packs of cardboard.
15 ml - bottles with drip (1) - packs of cardboard.
ATC codes
R01AA05 Oxymetazoline
Clinical-pharmacological groups / Group affiliation
Vasoconstricting preparation for local use in ENT practice
Active substance
oxymetazoline hydrochloride
Pharmaco-therapeutic group Rhinostop extra
Anticongestive agent - alpha-adrenomimetic
Pharmacological effect Rhinostop extra
Adrenomimetic agent for local use. It has a vasoconstrictive effect. Intranasal use reduces oedema of the mucous membrane of the upper respiratory tract.
Testimony Rhinostop extra
Difficulty in nasal breathing for colds, sinuses, eustainite, hay fever, allergic rhinitis.
To eliminate swelling before diagnostic manipulations in nasal passages.
Method of use, course and dosage Rhinostop extra
It is used intranasally.
Duration of application -three - five days.
- Nosology (ICD codes)
- H68
- Inflammation and blockage of the auditory [eustachian] tube
- J00
- Acute nasopharyngitis (runny nose)
- J01
- Acute sinusitis
- J30.1
- Allergic rhinitis caused by plant pollen
- J30.3
- Other allergic rhinitis (year-round allergic rhinitis)
- J31.0
- Chronic rhinitis
- J32
- Chronic sinusitis
- Z51.4
- Preparatory procedures for follow-up treatment or examination not classified elsewhere
